Fintel reports that on December 10, 2025, B. Riley Securities initiated coverage of Opus Genetics (NasdaqCM:IRD) with a Buy ...
As of Monday, December 15, Atossa Therapeutics, Inc.’s ATOS share price has dipped by 11.03%, which has investors questioning ...
Learn the key strategies growers say drive cannabis cultivation profitability – from vendor vetting to genetics, plant health and compliance.
If you’re looking to support your health goals heading into the new year, metabolism supplements may be able to help.
When genetics and fertility startup Nucleus Genomics plastered ads across New York City’s subway stations urging riders to ...
A major review of 111 resistance-training studies has identified the real rate of muscle growth: around 1.5kg in 10 weeks, ...
NEET UG 2026 is expected to witness intense competition, making NCERT-based preparation more crucial than ever for aspirants aiming for top medical colleges. Since the Biology section carries 90 ...
On Wednesday, the Therapeutic Goods Administration (TGA) approved NMN (nicotinamide mononucleotide) for use in Australia. The ...
Want to improve your health but not sure where to start? Here's how to build your own "longevity toolkit," according to ...
StockStory.org on MSN
Q3 Earnings Roundup: Myriad Genetics (NASDAQ:MYGN) And The Rest Of The Therapeutics Segment
Detailed price information for Myriad Genetics Inc (MYGN-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback